Nicaise Claude (CIK 1644162) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy SRPT (16,875 shares), Buy SRPT (10,500 shares), Sell SRPT (6,780 shares), Buy SRPT (9,746 shares), Sell SRPT (2,491 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 16,875 | $0 |
| 2026-01-29 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 10,500 | $143,955 |
| 2026-01-29 | Sarepta Therapeutics, Inc. (SRPT) | Director | Sell | 6,780 | $143,939 |
| 2025-03-13 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 9,746 | $245,404 |
| 2025-03-13 | Sarepta Therapeutics, Inc. (SRPT) | Director | Sell | 2,491 | $248,203 |
| 2025-03-11 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 2,383 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05